Intermittent catheters are generally catheters or tubes having a rounded tip connected to a distal end that is inserted into the bladder of a patient or user, and a molded funnel connected to a proximal end that remains outside the body of the patient or user. These types of catheters are typically utilized on a temporary basis to remove urine from the bladder of a patient or user. The distal tip may include slots or openings on the shaft to facilitate drainage of urine therefrom once the tip is positioned inside the bladder. Pre-wetted intermittent catheters are intermittent catheters having a highly lubricious coating on an outer surface thereof, which are packaged or otherwise brought into contact with fluid in order to provide a catheter with a slippery outer surface to facilitate insertion into the patient or user.
Intermittent catheters are well-known in the art, and include those disclosed in U.S. Pat. Nos. 5,895,374; 6,059,107; 6,634,498; 7,311,698; 6,849,070, 7,615,045; 6,736,805; 7,087,048; 7,380,658; and 6,355,004, the disclosures of which are all incorporated herein by reference in their entirety as if fully set forth herein.
The current offerings of pre-wetted intermittent catheters can be broken up into three broad categories. In the first type, the catheter is packaged in a dry environment, but contains a lubricious coating that requires a wetting fluid in order to become hydrated. The wetting fluid is obtained from an external source by the user (e.g., sink, bottled water, etc.) and the catheter is positioned within the wetting fluid for a period of time to become hydrated. Use of this first type of intermittent catheter may prove difficult in the event that drainage must be performed by the user when no clean water or wetting fluid is available. Moreover, sterility of the catheter may be compromised due to the handling of the catheter by the user as wetting fluid is applied and thereafter during insertion.
A second type of pre-wetted intermittent catheter is also packaged in a dry environment and contains a lubricious coating. In this second type, the wetting fluid is positioned in a pouch or container within the catheter package itself such that to hydrate the catheter, the pouch or container must be opened when the user is ready for insertion. A third type of pre-wetted intermittent catheter is packaged in a wet environment (i.e., the catheter is exposed to a wetting fluid within the catheter package).
Intermittent catheterization is generally performed a minimum of three times a day by the patient or a care giver in order to drain the bladder. The genital area near the urethral opening is wiped with an antiseptic agent, such as iodine. A lubricant may then be used to facilitate the entry of the catheter into the urethra. A topical local anesthetic may also be applied to numb the urethral opening during the procedure. The catheter packaging is opened, and the catheter is removed. One end of the catheter is placed in a container, and the other end is inserted into and guided up the urethra and into the bladder until urine flow begins.
Some patients requiring intermittent catheterization may have limited dexterity resulting from, for example, traumatic brain or spinal cord injury, or a disease state (e.g., spina bifida, multiple schlerosis). Such patients may have difficulty opening the packaging of an intermittent catheter, and may further have difficulty during insertion. Fumbling with the catheter and/or its packaging is potentially harmful to the patient, because the sterile surfaces of the catheter may become non-sterile. Inserting a non-sterile urinary catheter increases the likelihood of contracting a urinary tract infection.
Packaging is a separate issue associated with intermittent urinary catheterization. It could be desirable to provide an intermittent urinary catheter in a discrete, compact packaged unit to improve the ease of use, convenience, and privacy of the intermittent catheterization process for the user.
Thus, there is a need for an intermittent catheter that addresses at least one of the needs of the patient or user, e.g., is easy to use, is quick, clean, compact, capable of use with or without a bag, and is capable of maintaining sterility during insertion procedures.
Accordingly, a packaged urinary catheter is described herein, comprising a conduit having a proximal end and a distal end, wherein the distal end comprises at least one aperture for receiving urine from the bladder; a sleeve having a length, a width, and a size configured to receive the conduit, wherein the sleeve surrounds substantially the entire length of the conduit; and wherein the conduit and the sleeve are arranged in a helical coil.
In one embodiment, the shape of the helical coil is maintained by portions of the sleeve being releasably fixed together along at least a portion of the length of the sleeve.
In another embodiment, a first cap seals a proximal end of the sleeve, and a second cap seals a distal end of the sleeve.
In another embodiment, at least one of the first and second caps comprises a gripping feature configured to be grasped by a patient or user of the packaged urinary catheter.
In another embodiment, the gripping feature is sized and shaped to receive a finger therethrough.
In another embodiment, portions of the sleeve are releasably fixed together by a perforated section along a length of the sleeve.
In another embodiment, the packaged urinary catheter is released from the helical coil configuration by grasping the first and second caps, and urging the caps in substantially different directions.
In one embodiment, a lubricating material is contained within the sleeve.
In another embodiment, the lubricating material is chosen from water, a hydrogel, and a vapor.
In another embodiment, at least a portion of the outer surface of the conduit is hydrophilic.
In another embodiment, there is disclosed a synthetic polyisoprene conduit having a proximal end and a distal end, wherein the distal end comprises at least one aperture for receiving urine from the bladder; a sleeve having a length, and a width, and a size configured to receive the conduit, wherein the sleeve surrounds substantially the entire length of the conduit; and wherein the conduit and the sleeve are arranged in a helical coil.
These and other embodiments, methods, features and advantages will become more apparent to those skilled in the art when taken with reference to the following more detailed description of the invention in conjunction with the accompanying drawings that are first briefly described.
The following description should be read with reference to the drawings, in which like elements in different drawings are identically numbered. The drawings, which are not necessarily to scale, depict selected embodiments and are not intended to limit the scope of the invention. The detailed description illustrates by way of example, not by way of limitation, the principles of the invention. This description will clearly enable one skilled in the art to make and use the invention, and describes several embodiments, adaptations, variations, alternatives and uses of the invention, including what is presently believed to be the best mode of carrying out the invention.
As used herein, the reference terms “proximal” and “distal” (proximal being closer than distal) refer to the proximity with respect to a health care professional or other person other than a patient that is assisting the patient in using the catheter apparatus. In the case that a user is implementing the catheter apparatus without the aid of another, “proximal” and “distal” refer to the proximity with respect to a point external to the user's body. Thus, for example, a region or section of the catheter apparatus that is close to a health care professional or the user's hand when the catheter apparatus is being utilized is referred to as “proximal,” while a region or section of the catheter apparatus distanced from a health care professional or the user's hand when the catheter apparatus being used is referred to as “distal.”
The packaged catheter, as described herein, is discussed in the context of a urinary catheter for insertion into a user/patient bladder for drainage of urine therefrom. However, it should be appreciated that the packaged catheter described could also be used for other applications not specifically mentioned herein, and therefore should not be limited to a urinary catheter application.
Generally, the packaged catheter includes a conduit, such as a catheter or tube, positioned within a sleeve. The conduit may have a round cross-sectional shape, an oval cross-sectional shape, or any other cross-sectional shape that may facilitate insertion into a user's body, and in particular into a user's bladder through the urethra. The conduit, in accordance with various embodiments, contains a lubricious and/or antimicrobial coating on at least an outer surface thereof. The lubricious coating can include a hydrogel or any coating that renders the surface of the conduit hydrophilic. Suitable non-limiting examples of such coatings that may be used on the catheters disclosed herein may be found in U.S. Pat. Nos. 6,329,488; 6,716,895; 6,949,598; 7,179,849; and 8,784,928, filed Jan. 11, 2012, which is a National Phase application of International Application No. PCT/US2011/62086, titled “Deposition of a Silver Layer on a Non-Conducting Substrate,” and published as WO 2012/071536. Each of the above-listed patents, publications, and applications is incorporated by reference into this application as if fully set forth herein.
Referring now to
According to certain embodiments, the sleeve 20 is made of a gas impermeable material, such as a polymer, for example polypropylene or polyethylene. According to one embodiment, sleeve 20 is made of a non-rigid material, such as, for example, a foil material or the like, or films, such as polymeric films, for example polypropylene and polyethylene films. The sleeve may be constructed from two blanks of material that are joined at the edges to form the sleeve. The edges of the blanks may be joined by typical methods known to those of ordinary skill in the art, including heat, sonic, chemical, or physical bonding.
According to one embodiment, the sleeve 20 is configured to collapse upon itself to facilitate introduction of the conduit by a user and to prevent direct contact by the user with the conduit. The sleeve 20 may include an introduction member (not shown) at the proximal end thereof to facilitate introduction of the conduit to facilitate disposal of the drained urine. A suitable non-limiting example of an introducer is disclosed in U.S. Pat. No. 4,692,154 (the disclosure of which is incorporated herein by reference in its entirety).
According to various embodiments, the sleeve contains within it a wetting fluid. The purpose of the wetting fluid is to maintain hydration of a lubricious coating on the conduit 16 such that upon insertion of the conduit into a user, at least an outer portion thereof is extremely slippery, facilitating insertion.
The packaged catheter 10 includes first cap 24 for covering the proximal end 14 of conduit 16, and a second cap 22 for covering distal end 12 of conduit 16. The distal cap 22 has a lumen 36 (
Similarly, proximal cap 24 has a lumen 38 configured to receive the funnel 26 of conduit 16. According to one embodiment, the lumen 38 receives both the funnel and the proximal end of the sleeve 20. According to another embodiment, the proximal end of the sleeve 20 is releasably joined to the distal end of cap 24. According to yet another embodiment, the inside diameter of lumen 38 is releasably joined to the outside diameter of 20.
Patients who self-catheterize may have limited dexterity. Accordingly, it could be advantageous to provide caps 22 and 24 with grasping features to facilitate removal by those of limited dexterity. According to certain embodiments, caps 22 and 24 may have apertures 29 and 30, respectively, sized and shaped to receive at least one finger. Other grasping features known to those of ordinary skill in the art are also within the scope of the present disclosure.
According to certain embodiments, the sleeve 20 may have a tubular outer surface with a plurality of pre-formed pleats or folds (not shown) along a middle portion thereof between a proximal end section 32 and a distal end section 34 of packaged catheter 10. The pleats or folds in the outer surface of the sleeve 20 permit the sleeve to compress or collapse upon itself in accordion-like fashion. According to another embodiment, the sleeve 20 does not contain pre-formed pleats or folds, but instead is comprised of a thin, substantially flat, collapsible material.
The packaged catheter according to the present disclosure is designed to provide a compact configuration for discreet transport and usage. This may be accomplished by providing the catheter in a folded or coiled configuration. The present disclosure contemplates helical coils, as well as flat coils, or coils having any other configuration suitable for packaging. Such a configuration may allow a user to stow a sufficient number of catheters in a backpack, purse, or pocket while preserving the user's privacy and dignity.
Cap 24 is configured for removal from the distal end 14 of the packaged catheter, and urine is permitted to drain from funnel 26. In one embodiment, the drainage funnel 26 of the conduit 16 is configured such that it can be inserted into, or otherwise connected to, a bag 40 (
In one embodiment the bag includes an extension member (not shown) extending from an opening therein that both connects to the funnel 26 and is shaped to receive the cap 24. According to another embodiment, the bag has a closure member 42 at the distal end thereof, allowing the bag to be closed once the catheterization process is completed. According to another embodiment, the bag 40 is sized and shaped to hold a volume of urine and the used catheter and sleeve. According to yet another embodiment, the bag 40 is packaged together with the catheter. For example, the bag can be provided in a folded configuration in the center 3 of the coiled catheter (
According to one embodiment, and as exemplified in
The catheter may have a round or substantially round cross-sectional shape, an oval cross-sectional shape, or any other cross-sectional shape that may facilitate insertion into the body of a user/patient, and in particular, into the bladder of the user/patient through the urethra. According to various embodiments, the shape of the catheter can also be variable along its length.
Different lengths, sizes (e.g., diameter, width, etc.), and configurations are possible for the conduit 16, depending on the user's anatomy. For female users, the insertable length may range from 40 to 100 mm, for example 50 to 80 mm, such as 55 to 75 mm. For male users, the insertable length can range from 100 to 300 mm, such as 190 to 240 mm, for example 230 mm. For example, in one embodiment for an adult male human, the length of the conduit 16 may be in the range of about 8 to about 18 cm and have an elliptical cross-sectional shape similar to the shape of the male urethra.
The proximal end of the conduit 16 includes a tip having a rounded atraumatic shape (e.g., bullet shape, etc.) and at least one opening 18 or “eyes” in the sides of the tip that connect with a central conduit lumen such that placement of the conduit tip into a urine pool in the bladder results in drainage of urine therefrom. The tip design can vary according to the needs of a user, for example, the catheters disclosed herein can be provided with a coude tip.
As mentioned above, at least a portion of the outer surface of the conduit 16 is coated with a lubricious coating, which when contacted by a wetting fluid, becomes hydrated. The hydration of the lubricious coating results in a surface with a low coefficient of friction such that the conduit 16 is easily slidable into the body of a user. The lubricious coating is made from a material such as those described in U.S. Pat. No. 6,329,488 or 4,642,267, the disclosures of which are incorporated herein by reference in their entirety.
One of the advantages associated with the packaged catheter of the present disclosure is ease of use. From the coiled configuration, a user can grab each of caps 22 and 24, optionally through apertures 29 and 30, and urge the caps in substantially opposing directions shown by arrows A and B (
Referring now to the device as illustrated in
Once the bag 40 has been connected to the catheter apparatus 10 and the user is ready for insertion, the cap 22 is removed from the distal end 12 of the conduit 16, and the conduit tip is placed into the user. The user or assistant then holds the catheter apparatus 10 at a distal end (e.g., the user grasps the funnel 26 with one hand, and the sleeve 20 or washer 42 with the other hand) and pushes in a distal direction to extend the conduit 16 into the user and eventually into the user's bladder, while simultaneously collapsing the sleeve 20 onto itself. This action minimizes or eliminates exposure of the conduit 16 to conditions or contaminants outside of the container. Drainage of urine from the user's bladder then takes place and following evacuation, the proximal end of the catheter apparatus 10 is pulled in a proximal direction, while the distal end of the sleeve 20 (or the sealing member 42) is held in place. This action results in the conduit 16 returning fully inside the sleeve 20 so that the user or assistant is not exposed to potential contaminants. In the embodiment in which a bag 40 is attached to the proximal end 14 (or the funnel 26) of the catheter apparatus 10, the bag 40 is subsequently removed and disposed of (or emptied and sanitized). In an embodiment in which a bag 40 is not attached to the proximal end 14 or funnel 26 of the catheter apparatus 10, the funnel is directed into a disposal collection member or waste disposal apparatus, such as a toilet, during evacuation of the bladder.
The conduit 16 may be constructed from a suitable polymeric material, such as polyvinyl chloride (PVC), silicone, latex or other synthetic rubber. The components of the catheter disclosed herein can also be made from various well-known materials. For example, the portions of the assembly other than the conduit 16 can be made of polyvinyl propylene, polyvinyl chloride, polyethylene, polypropylene, and other types of suitable polymeric materials. The components can be molded or extruded according to well-known manufacturing techniques.
Materials commonly used to make the conduit 16 include, but are not limited to natural rubber latexes (available, for example, from Guthrie, Inc., Tucson, Ariz.; Firestone, Inc., Akron, Ohio; and Centrotrade USA, Virginia Beach, Va.), silicones (available, for example, from GE Silicones, Waterford, N.Y., Wacker Silicones, Adrian, Mich.; and Dow Corning, Inc., Midland, Mich.), polyvinyl chlorides (available, for example, from Kaneka Corp., Inc., New York, N.Y.), polyurethanes (available, for example, from Bayer, Inc., Toronto, Ontario, Rohm & Haas Company, Philadelphia, Pa.; and Ortec, Inc., Greenville, S.C.), plastisols (available, for example, from G S Industries, Bassett, Va.), polyvinyl acetate, (available, for example from Acetex Corp., Vancouver, British Columbia) polyacrylates (available, for example, from Rohm and Haas, Philadelphia, Pa.) and methacrylate copolymers (available, for example, from Heveatex, Inc., Fall River, Mass.). Synthetic and natural rubber latexes, polyurethanes, and silicones are preferred materials. Any combination of the foregoing materials may also be used in making catheters such as are used to produce latex Foley catheters.
The urinary catheter of the present disclosure can be manufactured by a variety of well-known methods. The tubing can be extruded and the funnel injection molded and then cut to the desired length. The tip of the tube can then be closed and rounded by thermoforming (for example, for PVC tubes) or molded (for example, for silicone tubes). Eye holes can then be punched or otherwise formed near the tip of the distal end of the tube to provide an outlet for urine drainage thru the tube when it is inserted into a bladder.
Alternatively, the entire catheter can be fabricated by dip molding. In this procedure, an elongated rod or “form” is dipped into a liquid coating material such as synthetic or natural rubber latex, for example, to form a layer of material on the form. The deposition of material can be increased by first dipping the form into a coagulant solution to coat the form with a film of chemical that causes the latex to coagulate onto the form. Calcium nitrate is commonly used as the coagulant, and other additives may be used to enhance the removal of the tube from the form once the catheter is formed and dried. The form has the shape and dimensions of the lumen of the catheter. The catheter may be formed from a single dip coating of the form or by multiple coating layers. When a suitable material thickness is achieved on a form, the forms are dried to produce the catheter. If multiple coatings are used to form the catheter, each coating may be dried before the next is applied. Once dried, the catheter may be stripped from the form. The catheters may then be washed and dried, and eyelets may then be formed thereon. Further manufacturing steps may be found in U.S. Pat. No. 7,628,784, the disclosure of which is incorporated by reference herein.
This invention has been described and specific examples of the invention have been portrayed. While the invention has been described in terms of particular variations and illustrative figures, those of ordinary skill in the art will recognize that the invention is not limited to the variations or figures described. In addition, where methods and steps described above indicate certain events occurring in certain order, those of ordinary skill in the art will recognize that the ordering of certain steps may be modified and that such modifications are in accordance with the variations of the invention. Additionally, certain of the steps may be performed concurrently in a parallel process when possible, as well as performed sequentially as described above. Therefore, to the extent there are variations of the invention, which are within the spirit of the disclosure or equivalent to the inventions found in the claims, it is the intent that this patent will cover those variations as well. Finally, all publications and patent applications cited in this specification are herein incorporated by reference in their entirety as if each individual publication or patent application were specifically and individually put forth herein.
This application is a continuation of U.S. patent application Ser. No. 14/681,023, filed Apr. 7, 2015, now U.S. Pat. No. 9,694,113, which is a continuation of U.S. patent application Ser. No. 13/802,095, filed Mar. 13, 2013, now U.S. Pat. No. 8,998,882, each of which is incorporated by reference in its entirety into this application.
Number | Name | Date | Kind |
---|---|---|---|
1888349 | Jacoby | Nov 1932 | A |
2912981 | Keough | Nov 1959 | A |
2919697 | Kim | Jan 1960 | A |
3173566 | Talbert | Mar 1965 | A |
3246075 | Dansard | Apr 1966 | A |
3344791 | Foderick | Oct 1967 | A |
3345988 | Vitello | Oct 1967 | A |
3556294 | Walck et al. | Jan 1971 | A |
3556874 | McClain | Jan 1971 | A |
3566874 | Shepherd et al. | Mar 1971 | A |
3648704 | Jackson | Mar 1972 | A |
3695921 | Shepherd et al. | Oct 1972 | A |
3699964 | Ericson | Oct 1972 | A |
3726281 | Norton et al. | Apr 1973 | A |
3794042 | De Klotz et al. | Feb 1974 | A |
3802987 | Noll | Apr 1974 | A |
3835992 | Adams, IV | Sep 1974 | A |
3854483 | Powers | Dec 1974 | A |
3861395 | Taniguchi | Jan 1975 | A |
3894540 | Bonner, Jr. | Jul 1975 | A |
3898993 | Taniguchi | Aug 1975 | A |
3934721 | Juster et al. | Jan 1976 | A |
3967728 | Gordon et al. | Jul 1976 | A |
4026296 | Stoy et al. | May 1977 | A |
4051849 | Poncy et al. | Oct 1977 | A |
4055682 | Merrill | Oct 1977 | A |
4062363 | Bonner, Jr. | Dec 1977 | A |
4069359 | DeMarse et al. | Jan 1978 | A |
4091922 | Egler | May 1978 | A |
4140127 | Cianci et al. | Feb 1979 | A |
4198983 | Becker et al. | Apr 1980 | A |
4230115 | Walz, Jr. et al. | Oct 1980 | A |
4245639 | La Rosa | Jan 1981 | A |
4246909 | Wu et al. | Jan 1981 | A |
4269310 | Uson et al. | May 1981 | A |
4306557 | North | Dec 1981 | A |
4350161 | Davis, Jr. | Sep 1982 | A |
4351333 | Lazarus et al. | Sep 1982 | A |
4366901 | Short | Jan 1983 | A |
4392848 | Lucas et al. | Jul 1983 | A |
4411648 | Davis et al. | Oct 1983 | A |
4515593 | Norton | May 1985 | A |
4517971 | Sorbonne | May 1985 | A |
4560382 | Isono et al. | Dec 1985 | A |
4571241 | Christopher | Feb 1986 | A |
4585666 | Lambert | Apr 1986 | A |
4597765 | Klatt | Jul 1986 | A |
4607746 | Stinnette | Aug 1986 | A |
4610670 | Spencer | Sep 1986 | A |
4619642 | Spencer | Oct 1986 | A |
4681572 | Tokarz et al. | Jul 1987 | A |
4692154 | Singery et al. | Sep 1987 | A |
4696672 | Mochizuki et al. | Sep 1987 | A |
4704102 | Guthery | Nov 1987 | A |
4723946 | Kay | Feb 1988 | A |
4738667 | Galloway | Apr 1988 | A |
4754877 | Johansson et al. | Jul 1988 | A |
4759753 | Schneider et al. | Jul 1988 | A |
4762128 | Rosenbluth | Aug 1988 | A |
4773901 | Norton | Sep 1988 | A |
4784651 | Hickey et al. | Nov 1988 | A |
4811847 | Reif et al. | Mar 1989 | A |
4838876 | Wong et al. | Jun 1989 | A |
4886508 | Washington | Dec 1989 | A |
4888005 | Dingeman et al. | Dec 1989 | A |
4893623 | Rosenbluth | Jan 1990 | A |
4932938 | Goldberg et al. | Jun 1990 | A |
4957487 | Gerow | Sep 1990 | A |
4997426 | Dingeman et al. | Mar 1991 | A |
5007897 | Kalb et al. | Apr 1991 | A |
5045078 | Asta | Sep 1991 | A |
5077352 | Elton | Dec 1991 | A |
5087252 | Denard | Feb 1992 | A |
5098379 | Conway et al. | Mar 1992 | A |
5100396 | Zamierowski | Mar 1992 | A |
5137671 | Conway et al. | Aug 1992 | A |
5147341 | Starke et al. | Sep 1992 | A |
5174290 | Fiddian-Green | Dec 1992 | A |
5179174 | Elton | Jan 1993 | A |
5180591 | Magruder et al. | Jan 1993 | A |
5186172 | Fiddian-Green | Feb 1993 | A |
5188596 | Condon et al. | Feb 1993 | A |
5201724 | Hukins et al. | Apr 1993 | A |
5209726 | Goosen | May 1993 | A |
5209728 | Kraus et al. | May 1993 | A |
5224953 | Morgentaler | Jul 1993 | A |
5226530 | Golden | Jul 1993 | A |
5234411 | Vaillancourt | Aug 1993 | A |
5236422 | Eplett, Jr. | Aug 1993 | A |
5242398 | Knoll et al. | Sep 1993 | A |
5242428 | Palestrant | Sep 1993 | A |
5261896 | Conway et al. | Nov 1993 | A |
5269755 | Bodicky | Dec 1993 | A |
5269770 | Conway et al. | Dec 1993 | A |
5282795 | Finney | Feb 1994 | A |
5352182 | Kalb et al. | Oct 1994 | A |
5360402 | Conway et al. | Nov 1994 | A |
5370899 | Conway et al. | Dec 1994 | A |
5415165 | Fiddian-Green | May 1995 | A |
5417666 | Coulter | May 1995 | A |
5433713 | Trotta | Jul 1995 | A |
5445626 | Gigante et al. | Aug 1995 | A |
5447231 | Kastenhofer | Sep 1995 | A |
5454798 | Kubalak et al. | Oct 1995 | A |
5456251 | Fiddian-Green | Oct 1995 | A |
5466229 | Elson et al. | Nov 1995 | A |
5476434 | Kalb et al. | Dec 1995 | A |
5482740 | Conway et al. | Jan 1996 | A |
5501669 | Conway et al. | Mar 1996 | A |
5509889 | Kalb et al. | Apr 1996 | A |
5514112 | Chu et al. | May 1996 | A |
5520636 | Korth et al. | May 1996 | A |
5531715 | Engelson et al. | Jul 1996 | A |
5531717 | Roberto et al. | Jul 1996 | A |
5536258 | Folden | Jul 1996 | A |
5558900 | Fan et al. | Sep 1996 | A |
5569219 | Hakki et al. | Oct 1996 | A |
5582599 | Daneshvar | Dec 1996 | A |
5591292 | Blomqvist | Jan 1997 | A |
5599321 | Conway et al. | Feb 1997 | A |
5601537 | Frassica | Feb 1997 | A |
5607417 | Batich et al. | Mar 1997 | A |
5616126 | Malekmehr et al. | Apr 1997 | A |
5624395 | Mikhail et al. | Apr 1997 | A |
5653700 | Byrne et al. | Aug 1997 | A |
5670111 | Conway et al. | Sep 1997 | A |
5688516 | Raad et al. | Nov 1997 | A |
5695456 | Cartmell | Dec 1997 | A |
5704353 | Kalb et al. | Jan 1998 | A |
5707357 | Mikhail et al. | Jan 1998 | A |
5711841 | Jaker | Jan 1998 | A |
5749826 | Faulkner | May 1998 | A |
5779670 | Bidwell et al. | Jul 1998 | A |
5782808 | Folden | Jul 1998 | A |
5785694 | Cohen et al. | Jul 1998 | A |
5788687 | Batich et al. | Aug 1998 | A |
5800339 | Salama | Sep 1998 | A |
5817067 | Tsukada et al. | Oct 1998 | A |
5820583 | Demopulos et al. | Oct 1998 | A |
5840151 | Munsch | Nov 1998 | A |
5848691 | Morris et al. | Dec 1998 | A |
5853518 | Utas et al. | Dec 1998 | A |
5871475 | Frassica | Feb 1999 | A |
5895374 | Rodsten et al. | Apr 1999 | A |
5897535 | Feliziani et al. | Apr 1999 | A |
5941856 | Kovacs et al. | Aug 1999 | A |
5958167 | Van Driel | Sep 1999 | A |
5971954 | Conway et al. | Oct 1999 | A |
5980483 | Dimitri et al. | Nov 1999 | A |
5989230 | Frassica | Nov 1999 | A |
6004305 | Hursman et al. | Dec 1999 | A |
6007521 | Bidwell et al. | Dec 1999 | A |
6024751 | Lovato et al. | Feb 2000 | A |
6050934 | Mikhail et al. | Apr 2000 | A |
6053905 | Daignault, Jr. et al. | Apr 2000 | A |
6056715 | Demopulos et al. | May 2000 | A |
6059107 | Nosted et al. | May 2000 | A |
6063063 | Harboe et al. | May 2000 | A |
6090075 | House | Jul 2000 | A |
6156049 | Lovato et al. | Dec 2000 | A |
6162201 | Cohen et al. | Dec 2000 | A |
6183461 | Matsuura et al. | Feb 2001 | B1 |
6186990 | Chen et al. | Feb 2001 | B1 |
6190353 | Makower et al. | Feb 2001 | B1 |
6210394 | Demopulos et al. | Apr 2001 | B1 |
6217569 | Fiore | Apr 2001 | B1 |
6221056 | Silverman | Apr 2001 | B1 |
6238383 | Karram et al. | May 2001 | B1 |
6254570 | Rutner et al. | Jul 2001 | B1 |
6254582 | O'Donnell et al. | Jul 2001 | B1 |
6254585 | Demopulos et al. | Jul 2001 | B1 |
6261279 | Demopulos et al. | Jul 2001 | B1 |
6293923 | Yachia et al. | Sep 2001 | B1 |
6299598 | Bander | Oct 2001 | B1 |
6306422 | Batich et al. | Oct 2001 | B1 |
6329488 | Terry et al. | Dec 2001 | B1 |
6340359 | Silverman | Jan 2002 | B1 |
6355004 | Pedersen et al. | Mar 2002 | B1 |
6358229 | Tihon | Mar 2002 | B1 |
6368315 | Gillis et al. | Apr 2002 | B1 |
6368317 | Chang | Apr 2002 | B2 |
6379334 | Frassica | Apr 2002 | B1 |
6383434 | Conway et al. | May 2002 | B2 |
6391010 | Wilcox | May 2002 | B1 |
6391014 | Silverman | May 2002 | B1 |
6398718 | Yachia et al. | Jun 2002 | B1 |
6402726 | Genese | Jun 2002 | B1 |
6409717 | Israelsson et al. | Jun 2002 | B1 |
6458867 | Wang et al. | Oct 2002 | B1 |
6468245 | Alexandersen et al. | Oct 2002 | B2 |
6485476 | von Dyck et al. | Nov 2002 | B1 |
6544240 | Borodulin et al. | Apr 2003 | B1 |
6578709 | Kavanagh et al. | Jun 2003 | B1 |
6582401 | Windheuser et al. | Jun 2003 | B1 |
6602244 | Kavanagh et al. | Aug 2003 | B2 |
6613342 | Aoki | Sep 2003 | B2 |
6626888 | Conway et al. | Sep 2003 | B1 |
6629969 | Chan et al. | Oct 2003 | B2 |
6634498 | Kayerod et al. | Oct 2003 | B2 |
6638269 | Wilcox | Oct 2003 | B2 |
6648906 | Lasheras et al. | Nov 2003 | B2 |
6659937 | Polsky et al. | Dec 2003 | B2 |
6682555 | Cioanta et al. | Jan 2004 | B2 |
6695831 | Tsukada et al. | Feb 2004 | B1 |
6711436 | Duhaylongsod | Mar 2004 | B1 |
6716895 | Terry | Apr 2004 | B1 |
6719709 | Whalen et al. | Apr 2004 | B2 |
6730113 | Eckhardt et al. | May 2004 | B2 |
6736805 | Israelsson et al. | May 2004 | B2 |
6746421 | Yachia et al. | Jun 2004 | B2 |
6783520 | Candray et al. | Aug 2004 | B1 |
D496266 | Nestenborg et al. | Sep 2004 | S |
6824532 | Gillis et al. | Nov 2004 | B2 |
6835183 | Lennox et al. | Dec 2004 | B2 |
6840379 | Franks-Farah et al. | Jan 2005 | B2 |
6848574 | Israelsson et al. | Feb 2005 | B1 |
6849070 | Hansen et al. | Feb 2005 | B1 |
6852105 | Bolmsjo et al. | Feb 2005 | B2 |
D503335 | Risberg et al. | Mar 2005 | S |
6869416 | Windheuser et al. | Mar 2005 | B2 |
6887230 | Kubalak et al. | May 2005 | B2 |
6889740 | Globensky et al. | May 2005 | B1 |
6918924 | Lasheras et al. | Jul 2005 | B2 |
6926708 | Franks-Farah et al. | Aug 2005 | B1 |
6939339 | Axexandersen et al. | Sep 2005 | B1 |
6941171 | Mann et al. | Sep 2005 | B2 |
6942634 | Odland | Sep 2005 | B2 |
6945957 | Freyman | Sep 2005 | B2 |
6949598 | Terry | Sep 2005 | B2 |
7001370 | Kubalak et al. | Feb 2006 | B2 |
7048717 | Frassica | May 2006 | B1 |
7059330 | Makower et al. | Jun 2006 | B1 |
7066912 | Nestenborg et al. | Jun 2006 | B2 |
7087041 | von Dyck et al. | Aug 2006 | B2 |
7087048 | Israelsson et al. | Aug 2006 | B2 |
7094220 | Tanghoj et al. | Aug 2006 | B2 |
7160277 | Elson et al. | Jan 2007 | B2 |
7166092 | Elson et al. | Jan 2007 | B2 |
7195608 | Burnett | Mar 2007 | B2 |
7244242 | Freyman | Jul 2007 | B2 |
7250043 | Chan et al. | Jul 2007 | B2 |
7255687 | Huang et al. | Aug 2007 | B2 |
7270647 | Karpowicz et al. | Sep 2007 | B2 |
7294117 | Provost-tine et al. | Nov 2007 | B2 |
7311690 | Burnett | Dec 2007 | B2 |
7311698 | Tanghoj et al. | Dec 2007 | B2 |
7331948 | Skarda | Feb 2008 | B2 |
7334679 | Givens, Jr. | Feb 2008 | B2 |
7374040 | Lee et al. | May 2008 | B2 |
7380658 | Murray et al. | Jun 2008 | B2 |
7445812 | Schmidt et al. | Nov 2008 | B2 |
7458964 | Mosler et al. | Dec 2008 | B2 |
7476223 | McBride | Jan 2009 | B2 |
7507229 | Hewitt et al. | Mar 2009 | B2 |
7517343 | Tanghoj et al. | Apr 2009 | B2 |
7537589 | Tsukada et al. | May 2009 | B2 |
7571804 | Kjellmann Bruun et al. | Aug 2009 | B2 |
7601158 | House | Oct 2009 | B2 |
7615045 | Israelsson et al. | Nov 2009 | B2 |
7628784 | Diaz et al. | Dec 2009 | B2 |
7632256 | Mosler et al. | Dec 2009 | B2 |
7662146 | House | Feb 2010 | B2 |
7682353 | Tanghoj et al. | Mar 2010 | B2 |
7770726 | Murray et al. | Aug 2010 | B2 |
7789873 | Kubalak et al. | Sep 2010 | B2 |
7823722 | Bezou et al. | Nov 2010 | B2 |
7846133 | Windheuser et al. | Dec 2010 | B2 |
7938838 | House | May 2011 | B2 |
7947021 | Bourne et al. | May 2011 | B2 |
7985217 | Mosler et al. | Jul 2011 | B2 |
8011505 | Murray et al. | Sep 2011 | B2 |
8051981 | Murray et al. | Nov 2011 | B2 |
8066693 | Tanghoj et al. | Nov 2011 | B2 |
8177774 | House | May 2012 | B2 |
8181778 | Van Groningen et al. | May 2012 | B1 |
8205745 | Murray et al. | Jun 2012 | B2 |
8328792 | Nishtala et al. | Dec 2012 | B2 |
8454569 | Kull-Osterlin et al. | Jun 2013 | B2 |
8459455 | Frojd | Jun 2013 | B2 |
8475434 | Frojd | Jul 2013 | B2 |
8998882 | Knapp et al. | Apr 2015 | B2 |
9033149 | Terry | May 2015 | B2 |
9114227 | Blanchard | Aug 2015 | B2 |
9694113 | Knapp et al. | Jul 2017 | B2 |
9731093 | Terry | Aug 2017 | B2 |
9821139 | Carleo | Nov 2017 | B2 |
10149961 | Carleo | Dec 2018 | B2 |
20010001443 | Kayerod et al. | May 2001 | A1 |
20010031952 | Karram et al. | Oct 2001 | A1 |
20010047147 | Slepian et al. | Nov 2001 | A1 |
20010054562 | Pettersson et al. | Dec 2001 | A1 |
20020007175 | Chang | Jan 2002 | A1 |
20020037943 | Madsen | Mar 2002 | A1 |
20020045855 | Frassica | Apr 2002 | A1 |
20020055730 | Yachia et al. | May 2002 | A1 |
20020077611 | von Dyck et al. | Jun 2002 | A1 |
20020082551 | Yachia et al. | Jun 2002 | A1 |
20020087131 | Wolff et al. | Jul 2002 | A1 |
20020094322 | Lawson et al. | Jul 2002 | A1 |
20020095133 | Gillis et al. | Jul 2002 | A1 |
20020099356 | Unger et al. | Jul 2002 | A1 |
20020103467 | Kubalak | Aug 2002 | A1 |
20020107467 | Levin | Aug 2002 | A1 |
20020132013 | Moulis | Sep 2002 | A1 |
20020133130 | Wilcox | Sep 2002 | A1 |
20020156440 | Israelsson et al. | Oct 2002 | A1 |
20020165427 | Yachia et al. | Nov 2002 | A1 |
20030004496 | Tanghoj | Jan 2003 | A1 |
20030018293 | Tanghoj et al. | Jan 2003 | A1 |
20030018302 | Kavanagh et al. | Jan 2003 | A1 |
20030018322 | Tanghoj et al. | Jan 2003 | A1 |
20030028174 | Chan et al. | Feb 2003 | A1 |
20030036802 | Lennox et al. | Feb 2003 | A1 |
20030055403 | Nestenborg et al. | Mar 2003 | A1 |
20030060807 | Tanghoj et al. | Mar 2003 | A1 |
20030065292 | Darouiche et al. | Apr 2003 | A1 |
20030130646 | Kubalak et al. | Jul 2003 | A1 |
20030132307 | Park | Jul 2003 | A1 |
20030135200 | Byrne | Jul 2003 | A1 |
20030163079 | Burnett | Aug 2003 | A1 |
20030195478 | Russo | Oct 2003 | A1 |
20030225392 | McMichael et al. | Dec 2003 | A1 |
20030233084 | Slepian et al. | Dec 2003 | A1 |
20040030301 | Hunter | Feb 2004 | A1 |
20040034329 | Mankus et al. | Feb 2004 | A1 |
20040044307 | Richardson et al. | Mar 2004 | A1 |
20040049152 | Nayak | Mar 2004 | A1 |
20040049170 | Snell | Mar 2004 | A1 |
20040055925 | Franks-Farah et al. | Mar 2004 | A1 |
20040059280 | Makower et al. | Mar 2004 | A1 |
20040068251 | Chan et al. | Apr 2004 | A1 |
20040074794 | Conway et al. | Apr 2004 | A1 |
20040116551 | Terry | Jun 2004 | A1 |
20040127848 | Freyman | Jul 2004 | A1 |
20040133156 | Diaz et al. | Jul 2004 | A1 |
20040147871 | Burnett | Jul 2004 | A1 |
20040153049 | Hewitt et al. | Aug 2004 | A1 |
20040153051 | Israelsson et al. | Aug 2004 | A1 |
20040158231 | Tanghoj et al. | Aug 2004 | A1 |
20040163980 | Tanghoj et al. | Aug 2004 | A1 |
20040176747 | Feneley | Sep 2004 | A1 |
20040243104 | Seddon | Dec 2004 | A1 |
20040249343 | Cioanta | Dec 2004 | A1 |
20040254562 | Tanghoj et al. | Dec 2004 | A1 |
20040256264 | Israelsson et al. | Dec 2004 | A1 |
20050003118 | Takala | Jan 2005 | A1 |
20050015076 | Giebmeyer et al. | Jan 2005 | A1 |
20050031872 | Schmidt et al. | Feb 2005 | A1 |
20050033222 | Haggstrom et al. | Feb 2005 | A1 |
20050043715 | Nestenborg et al. | Feb 2005 | A1 |
20050049577 | Snell et al. | Mar 2005 | A1 |
20050059990 | Ayala et al. | Mar 2005 | A1 |
20050065499 | Douk et al. | Mar 2005 | A1 |
20050070882 | McBride | Mar 2005 | A1 |
20050080399 | Bolmsjo et al. | Apr 2005 | A1 |
20050096582 | Burnett | May 2005 | A1 |
20050101923 | Elson et al. | May 2005 | A1 |
20050101924 | Elson et al. | May 2005 | A1 |
20050107735 | Lennox et al. | May 2005 | A1 |
20050109648 | Kerzman et al. | May 2005 | A1 |
20050137522 | Aoki | Jun 2005 | A1 |
20050137582 | Kull-Osterlin et al. | Jun 2005 | A1 |
20050143690 | High | Jun 2005 | A1 |
20050148950 | Windheuser et al. | Jul 2005 | A1 |
20050197531 | Cabiri et al. | Sep 2005 | A1 |
20050199521 | Givens | Sep 2005 | A1 |
20050209580 | Freyman | Sep 2005 | A1 |
20050214443 | Madsen | Sep 2005 | A1 |
20050245901 | Floyd | Nov 2005 | A1 |
20050251108 | Frassica | Nov 2005 | A1 |
20050256447 | Richardson et al. | Nov 2005 | A1 |
20050273034 | Burnett | Dec 2005 | A1 |
20050283136 | Skarda | Dec 2005 | A1 |
20060025753 | Kubalak et al. | Feb 2006 | A1 |
20060027854 | Kim et al. | Feb 2006 | A1 |
20060030864 | Kennedy et al. | Feb 2006 | A1 |
20060036208 | Burnett | Feb 2006 | A1 |
20060041246 | Provost-tine et al. | Feb 2006 | A1 |
20060054557 | Hori et al. | Mar 2006 | A1 |
20060058777 | Nielsen | Mar 2006 | A1 |
20060064065 | Russo | Mar 2006 | A1 |
20060079835 | Frassica | Apr 2006 | A1 |
20060079854 | Kay et al. | Apr 2006 | A1 |
20060100511 | Eriksen | May 2006 | A1 |
20060122566 | Huang et al. | Jun 2006 | A1 |
20060122568 | Elson et al. | Jun 2006 | A1 |
20060163097 | Murray et al. | Jul 2006 | A1 |
20060172096 | Kyle et al. | Aug 2006 | A1 |
20060184112 | Horn et al. | Aug 2006 | A1 |
20060184145 | Ciok et al. | Aug 2006 | A1 |
20060196783 | Bruun et al. | Sep 2006 | A1 |
20060200079 | Magnusson | Sep 2006 | A1 |
20060263404 | Nielsen et al. | Nov 2006 | A1 |
20060271019 | Stoller et al. | Nov 2006 | A1 |
20060276894 | Finley | Dec 2006 | A1 |
20060278546 | State et al. | Dec 2006 | A1 |
20060293642 | Israelsson et al. | Dec 2006 | A1 |
20070005041 | Frassica et al. | Jan 2007 | A1 |
20070010798 | Stoller et al. | Jan 2007 | A1 |
20070016169 | Utas et al. | Jan 2007 | A1 |
20070049879 | Gutierrez | Mar 2007 | A1 |
20070066963 | Tanghoj | Mar 2007 | A1 |
20070106233 | Huang et al. | May 2007 | A1 |
20070112327 | Yun et al. | May 2007 | A1 |
20070149929 | Utas et al. | Jun 2007 | A1 |
20070197957 | Hunter et al. | Aug 2007 | A1 |
20070225635 | Lynn | Sep 2007 | A1 |
20070225649 | House | Sep 2007 | A1 |
20070225687 | House | Sep 2007 | A1 |
20070244449 | Najafi et al. | Oct 2007 | A1 |
20070289887 | Murray et al. | Dec 2007 | A1 |
20080006554 | Duffy et al. | Jan 2008 | A1 |
20080015518 | Huang et al. | Jan 2008 | A1 |
20080021382 | Freyman | Jan 2008 | A1 |
20080027414 | Tanghoj et al. | Jan 2008 | A1 |
20080033471 | Paz et al. | Feb 2008 | A1 |
20080050446 | Ziegler et al. | Feb 2008 | A1 |
20080051762 | Tsukada et al. | Feb 2008 | A1 |
20080051763 | Frojd | Feb 2008 | A1 |
20080077099 | House | Mar 2008 | A1 |
20080082051 | Miller et al. | Apr 2008 | A1 |
20080085949 | McGhee | Apr 2008 | A1 |
20080091145 | House | Apr 2008 | A1 |
20080097362 | Mosler et al. | Apr 2008 | A1 |
20080097394 | Lampropoulos et al. | Apr 2008 | A1 |
20080097411 | House | Apr 2008 | A1 |
20080140010 | Kennedy et al. | Jun 2008 | A1 |
20080140052 | Moller et al. | Jun 2008 | A1 |
20080171973 | House | Jul 2008 | A1 |
20080171998 | House | Jul 2008 | A1 |
20080172016 | House | Jul 2008 | A1 |
20080172042 | House | Jul 2008 | A1 |
20080179208 | Murray et al. | Jul 2008 | A1 |
20080200907 | Nestenborg | Aug 2008 | A1 |
20080243091 | Humphreys et al. | Oct 2008 | A1 |
20080249467 | Burnett et al. | Oct 2008 | A1 |
20080249482 | Erez | Oct 2008 | A1 |
20080275463 | High | Nov 2008 | A1 |
20090024111 | Borodulin et al. | Jan 2009 | A1 |
20090048537 | Lydon et al. | Feb 2009 | A1 |
20090054876 | Borodulin et al. | Feb 2009 | A1 |
20090065605 | Roche et al. | Mar 2009 | A1 |
20090071851 | Maki et al. | Mar 2009 | A1 |
20090099532 | Cuevas et al. | Apr 2009 | A1 |
20090131917 | Kavanagh et al. | May 2009 | A1 |
20090137985 | Tanghoej et al. | May 2009 | A1 |
20090137986 | Golden et al. | May 2009 | A1 |
20090149837 | Tanghoj et al. | Jun 2009 | A1 |
20090156882 | Chi Sing et al. | Jun 2009 | A1 |
20090200187 | Nestenborg et al. | Aug 2009 | A1 |
20090299334 | Nishtala et al. | Dec 2009 | A1 |
20090318900 | Tanghoj et al. | Dec 2009 | A1 |
20100198195 | Nishtala et al. | Aug 2010 | A1 |
20100228233 | Kahn | Sep 2010 | A1 |
20100263327 | Murray et al. | Oct 2010 | A1 |
20100324540 | Paulen et al. | Dec 2010 | A1 |
20110028943 | Lawson et al. | Feb 2011 | A1 |
20110056852 | Frojd | Mar 2011 | A1 |
20110114520 | Matthison-Hansen | May 2011 | A1 |
20110127186 | Enns et al. | Jun 2011 | A1 |
20110137296 | Tanghoj | Jun 2011 | A1 |
20110184386 | House | Jul 2011 | A1 |
20120168324 | Carleo | Jul 2012 | A1 |
20120179102 | Blanchard et al. | Jul 2012 | A1 |
20120308805 | Sella | Dec 2012 | A1 |
20120316515 | Terry | Dec 2012 | A1 |
20130006226 | Hong et al. | Jan 2013 | A1 |
20130048516 | Nishtala et al. | Feb 2013 | A1 |
20130153446 | Utas et al. | Jun 2013 | A1 |
20130186778 | Terry | Jul 2013 | A1 |
20140262859 | Knapp et al. | Sep 2014 | A1 |
20150238726 | Terry | Aug 2015 | A1 |
20150273116 | Knapp et al. | Oct 2015 | A1 |
20170326334 | Terry | Nov 2017 | A1 |
Number | Date | Country |
---|---|---|
2770300 | Feb 2011 | CA |
2769026 | Apr 2015 | CA |
102939127 | Feb 2013 | CN |
100 38 521 | Feb 2002 | DE |
10213411 | Oct 2003 | DE |
0217771 | Apr 1987 | EP |
247559 | Dec 1987 | EP |
0252918 | Jan 1988 | EP |
0479935 | Apr 1992 | EP |
0677299 | Oct 1995 | EP |
0699086 | Mar 1996 | EP |
0815037 | Jan 1998 | EP |
0909249 | Apr 1999 | EP |
0923398 | Jun 1999 | EP |
0935478 | Aug 1999 | EP |
0959930 | Dec 1999 | EP |
0977610 | Feb 2000 | EP |
1023882 | Aug 2000 | EP |
1090656 | Apr 2001 | EP |
1115450 | Jul 2001 | EP |
1131022 | Sep 2001 | EP |
1145729 | Oct 2001 | EP |
1175355 | Jan 2002 | EP |
1237615 | Sep 2002 | EP |
1245205 | Oct 2002 | EP |
1308146 | May 2003 | EP |
1406690 | Apr 2004 | EP |
1409060 | Apr 2004 | EP |
1420846 | May 2004 | EP |
1420847 | May 2004 | EP |
1427467 | Jun 2004 | EP |
1498151 | Jan 2005 | EP |
1629860 | Mar 2006 | EP |
1641510 | Apr 2006 | EP |
1642610 | Apr 2006 | EP |
1642611 | Apr 2006 | EP |
2060296 | May 2009 | EP |
2459264 | Jun 2012 | EP |
2464411 | Jun 2012 | EP |
2515988 | Oct 2012 | EP |
2542291 | Jan 2013 | EP |
3078393 | Nov 2017 | EP |
2967968 | Sep 2018 | EP |
2731345 | Sep 1996 | FR |
2 794 638 | Dec 2000 | FR |
2284764 | Jun 1995 | GB |
2319507 | May 1998 | GB |
S55-12265 | Mar 1980 | JP |
2001-500414 | Jan 2001 | JP |
2002-530148 | Sep 2002 | JP |
2002 282275 | Oct 2002 | JP |
2007-501656 | Feb 2007 | JP |
2011-510110 | Mar 2011 | JP |
2013-500125 | Jan 2013 | JP |
2013-515572 | May 2013 | JP |
2009105497 | Aug 2010 | RU |
198401296 | Apr 1984 | WO |
1986006284 | Nov 1986 | WO |
1991005577 | May 1991 | WO |
1994016747 | Aug 1994 | WO |
1996038192 | Dec 1996 | WO |
1997026937 | Jul 1997 | WO |
1997041811 | Nov 1997 | WO |
1998006642 | Feb 1998 | WO |
1998011932 | Mar 1998 | WO |
1998019729 | May 1998 | WO |
9846176 | Oct 1998 | WO |
1999030761 | Jun 1999 | WO |
2000016843 | Mar 2000 | WO |
2000047494 | Aug 2000 | WO |
2001043807 | Jun 2001 | WO |
2001052763 | Jul 2001 | WO |
2001093935 | Dec 2001 | WO |
2002036192 | May 2002 | WO |
2003002177 | Jan 2003 | WO |
2003002178 | Jan 2003 | WO |
2003008028 | Jan 2003 | WO |
2003008029 | Jan 2003 | WO |
2003064279 | Aug 2003 | WO |
2003092779 | Nov 2003 | WO |
2004030722 | Apr 2004 | WO |
2004045696 | Jun 2004 | WO |
2004045696 | Jun 2004 | WO |
2004050155 | Jun 2004 | WO |
2004052440 | Jun 2004 | WO |
2004056414 | Jul 2004 | WO |
2004075944 | Sep 2004 | WO |
2004089454 | Oct 2004 | WO |
2005004964 | Jan 2005 | WO |
2005014055 | Feb 2005 | WO |
2005061035 | Jul 2005 | WO |
2005092418 | Oct 2005 | WO |
2007050685 | May 2007 | WO |
2007050685 | May 2007 | WO |
2009012336 | Jan 2009 | WO |
2007050685 | Apr 2009 | WO |
2011014201 | Feb 2011 | WO |
2011019359 | Feb 2011 | WO |
2011063816 | Jun 2011 | WO |
2011079129 | Jun 2011 | WO |
2011109393 | Sep 2011 | WO |
2014165046 | Oct 2014 | WO |
Entry |
---|
U.S. Appl. No. 13/516,660, filed Aug. 27, 2012 Board Decision dated Jan. 22, 2019. |
U.S. Appl. No. 15/669,697, filed Aug. 4, 2017 Non-Final Office Action dated Oct. 18, 2018. |
“Tripartite Biocompatibility Guidance for Medical Devices,” DSMA (Apr. 24, 1987). |
BR PI 0506836-3 filed Jan. 18, 2005, Technical Report dated Jul. 28, 2015. |
CA 2,769,026 filed Jan. 24, 2012 First Examination Report dated Nov. 4, 2013. |
CN 201080058895.4 filed Jun. 21, 2012 First Office Action dated Feb. 27, 2014. |
CN 201080058895.4 filed Jun. 21, 2012 Second Office Action dated Nov. 3, 2014. |
CN 201080058895.4 filed Jun. 21, 2012 Third Office Action dated May 4, 2015. |
CN 201480013064.3 filed Sep. 8, 2015 Office Action dated Oct. 10, 2016. |
EP 09848341.5 filed Feb. 27, 2012 extended European Search Report dated Apr. 4, 2013. |
EP 09848341.5 filed Feb. 27, 2012 supplemental European Search Report dated Nov. 8, 2013. |
EP 10840071.4 filed Jul. 4, 2012 Exam Report dated Apr. 29, 2014. |
EP 10840071.4 filed Jul. 4, 2012 extended European Search Report dated Apr. 17, 2013. |
EP 10840071.4 filed Jul. 4, 2012 Notice of Opposition dated Apr. 24, 2017. |
EP 10840071.4 filed Jul. 4, 2012 Office Action dated Jul. 9, 2015. |
EP 11751198.0 filed Sep. 28, 2012 Exam Report dated Feb. 7, 2014. |
EP 11751198.0 filed Sep. 28, 2012 extended European search report dated Jul. 9, 2013. |
EP 14779919.1 filed Sep. 10, 2015 Extended European Search Report dated Aug. 23, 2016. |
EP 16171279.9 filed May 25, 2016 Extended European Search Report, dated Aug. 23, 2016. |
JP 2012-546157 filed Jun. 12, 2012 Decision of Rejection dated Aug. 21, 2015. |
JP 2012-546157 filed Jun. 12, 2012 First Office Action dated Sep. 16, 2014. |
JP 2015-243156 filed Dec. 14, 2015 Office Action dated Sep. 16, 2016. |
Norton, J.A. et al., Surgery: Basic Science and Clinical Evidence Springer, 2nd ed., 2008, p. 281. |
PCT/US2006/041633 filed Oct. 25, 2006 International Preliminary Report on Patentability dated Mar. 24, 2009. |
PCT/US2006/041633 filed Oct. 25, 2006 Search Report dated Aug. 12, 2008. |
PCT/US2006/041633 filed Oct. 25, 2006 Written Opinion dated Aug. 12, 2008. |
PCT/US2009/055389 filed Aug. 28, 2009 International Search Report dated Oct. 20, 2009. |
PCT/US2009/055389 filed Aug. 28, 2009 Written Opinion dated Oct. 20, 2009. |
PCT/US2009/055395 filed Aug. 28, 2009 International Preliminary Report on Patentability dated Jan. 31, 2012. |
PCT/US2009/055395 filed Aug. 28, 2009 International Search Report dated Oct. 15, 2009. |
PCT/US2009/055395 filed Aug. 28, 2009 Written Opinion dated Oct. 15, 2009. |
PCT/US2010/061597 filed Dec. 21, 2010 International Preliminary Report on Patentability dated Jun. 26, 2012 and Written Opinion dated Feb. 28, 2011. |
PCT/US2010/061597 filed Dec. 21, 2010 International Search Report dated Feb. 28, 2011. |
PCT/US2011/026681 filed Mar. 1, 2011 International Preliminary Report on Patentability dated Sep. 4, 2012. |
PCT/US2011/026681 filed Mar. 1, 2011 International Search Report dated Apr. 27, 2011. |
PCT/US2011/026681 filed Mar. 1, 2011 Written Opinion dated Apr. 27, 2011. |
PCT/US2014/024231 filed Mar. 12, 2014 International Search Report and Written Opinion dated Jul. 10, 2014. |
U.S. Appl. No. 12/091,916, filed Feb. 2, 2009 Final Office Action dated Sep. 22, 2011. |
U.S. Appl. No. 12/091,916, filed Feb. 2, 2009 Non-Final Office Action dated May 10, 2011. |
U.S. Appl. No. 12/091,916, filed Feb. 2, 2009 Non-Final Office Action dated Nov. 24, 2010. |
U.S. Appl. No. 12/091,916, filed Feb. 2, 2009 Notice of Allowance dated Aug. 17, 2012. |
U.S. Appl. No. 13/387,447, filed Mar. 22, 2012 Advisory Action dated Feb. 27, 2014. |
U.S. Appl. No. 13/387,447, filed Mar. 22, 2012 Examiner's Answer dated Oct. 5, 2016. |
U.S. Appl. No. 13/387,447, filed Mar. 22, 2012 Final Office Action dated Dec. 11, 2013. |
U.S. Appl. No. 13/387,447, filed Mar. 22, 2012 Final Office Action dated Oct. 31, 2014. |
U.S. Appl. No. 13/387,447, filed Mar. 22, 2012 Final Office Action dated Oct. 5, 2015. |
U.S. Appl. No. 13/387,447, filed Mar. 22, 2012 Non-Final Office Action dated Jan. 15, 2013. |
U.S. Appl. No. 13/387,447, filed Mar. 22, 2012 Non-Final Office Action dated Jul. 15, 2014. |
U.S. Appl. No. 13/387,447, filed Mar. 22, 2012 Non-Final Office Action dated Jun. 6, 2013. |
U.S. Appl. No. 13/387,447, filed Mar. 22, 2012 Non-Final Office Action dated Mar. 12, 2015. |
U.S. Appl. No. 13/389,753, filed Mar. 20, 2012 Decision on Appeal dated Jun. 29, 2017. |
U.S. Appl. No. 13/389,753, filed Mar. 20, 2012 Examiner's Answer dated Aug. 27, 2015. |
AU 2014248744 filed Jul. 9, 2015 Examiner's Report dated Jul. 26, 2017. |
CN 201480013064.3 filed Sep. 8, 2015 Office Action dated Jun. 29, 2017. |
EP 14779919.1 filed Sep. 10, 2015 Office Action dated Jul. 4, 2017. |
EP 16171279.9 filed May 25, 2016 Intent to Grant, dated Jun. 13, 2017. |
EP 17201044.9 filed Nov. 10, 2017 Extended European Search Report dated Jan. 18, 2018. |
JP 2016-501444 filed Sep. 11, 2015 Office Action dated Dec. 14, 2017. |
Mx/a/2015/009904 filed Jul. 30, 2015 Office Action dated Jun. 29, 2018. |
RU 2015140616 filed Sep. 24, 2015 Office Action dated Feb. 21, 2018. |
U.S. Appl. No. 13/387,447, filed Mar. 22, 2012 Notice of Allowance dated Jul. 30, 2018. |
U.S. Appl. No. 13/387,447, filed Mar. 22, 2012 Patent Board Decision dated Jun. 1, 2018. |
U.S. Appl. No. 13/389,753, filed Mar. 20, 2012 Notice of Allowance dated Jul. 5, 2017. |
U.S. Appl. No. 13/516,660, filed Aug. 27, 2012 Examiner's Answre dated Nov. 22, 2017. |
U.S. Appl. No. 13/662,278, filed Oct. 26, 2012 Board Decision dated Aug. 23, 2018. |
U.S. Appl. No. 13/389,753, filed Mar. 20, 2012 Final Office Action dated Dec. 10, 2014. |
U.S. Appl. No. 13/389,753, filed Mar. 20, 2012 Non-Final Office Action dated Jul. 21, 2014. |
U.S. Appl. No. 13/516,660, filed Aug. 27, 2012 Advisory Action dated Sep. 22, 2016. |
U.S. Appl. No. 13/516,660, filed Aug. 27, 2012 Final Office Action dated Jun. 29, 2016. |
U.S. Appl. No. 13/516,660, filed Aug. 27, 2012 Non-Final Office Action dated Mar. 8, 2016. |
U.S. Appl. No. 13/582,698, filed Sep. 4, 2012 Non-Final Office Action dated Sep. 24, 2014. |
U.S. Appl. No. 13/662,278, filed Oct. 26, 2012 Examiner's Answer dated Jun. 2, 2017. |
U.S. Appl. No. 13/662,278, filed Oct. 26, 2012 Final Office Action dated Feb. 20, 2015. |
U.S. Appl. No. 13/662,278, filed Oct. 26, 2012 Final Office Action dated Oct. 19, 2016. |
U.S. Appl. No. 13/662,278, filed Oct. 26, 2012 Non-Final Office Action dated Jul. 7, 2016. |
U.S. Appl. No. 13/662,278, filed Oct. 26, 2012 Non-Final Office Action dated Sep. 12, 2014. |
U.S. Appl. No. 13/662,278, filed Oct. 26, 2012 Non-Final Office Action dated Sep. 17, 2015. |
U.S. Appl. No. 13/802,095, filed Mar. 13, 2013 Non-Final Office Action dated Aug. 15, 2014. |
U.S. Appl. No. 13/802,095, filed Mar. 13, 2013 Notice of Allowance dated Nov. 28, 2014. |
U.S. Appl. No. 14/681,023, filed Apr. 7, 2015 Non-Final Office Action dated Nov. 9, 2016. |
U.S. Appl. No. 14/681,023, filed Apr. 7, 2015 Notice of Allowance dated Mar. 8, 2017. |
U.S. Appl. No. 14/707,954, filed May 8, 2015 Non-Final Office Action dated Dec. 1, 2016. |
EP 17201044.9 filed Nov. 10, 2017 Office Action dated Jul. 4, 2019. |
Piyush Gupta et al. Hydrogels: from controlled release to pH-responsive drug delivery, May 2002, DDT vol. 7, No. 10, pp. 569-579. (Year 2002). |
U.S. Appl. No. 13/516,660, filed Aug. 27, 2012 Non-Final Office Action dated Mar. 15, 2019. |
U.S. Appl. No. 15/669,697, filed Aug. 4, 2017 Notice of Allowance dated Mar. 1, 2019. |
Number | Date | Country | |
---|---|---|---|
20170296704 A1 | Oct 2017 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14681023 | Apr 2015 | US |
Child | 15639844 | US | |
Parent | 13802095 | Mar 2013 | US |
Child | 14681023 | US |